Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.80
Bid: 35.60
Ask: 38.00
Change: 0.00 (0.00%)
Spread: 2.40 (6.742%)
Open: 36.80
High: 36.80
Low: 36.80
Prev. Close: 36.80
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Frontier partners University of Lisbon competition

19 Mar 2020 07:00

RNS Number : 7165G
Frontier IP Group plc
19 March 2020
 

RNS Reach 

AIM: FIPP 

19 March 2020  

 

 

Frontier IP Group plc

("Frontier IP" or the "Group")

 

Frontier IP becomes partner in prestigious University of Lisbon technology transfer competition ScienceIN2Business

 

Frontier IP, a specialist in commercialising university intellectual property, today announces its involvement with the University of Lisbon (the "University") ScienceIN2Business programme, powered by Faculdade de Ciências - Tec labs, to identify promising science and technologies being developed by its academics and students.

 

ScienceIN2Business invites academics to put forward projects with commercial potential, from which a final five are chosen to be taken further. The Group will provide mentoring support and expert advice to the projects entered and will be involved in selecting the shortlist.

 

The University of Lisbon is Portugal's top-rated university in both the Shanghai and CWTS Leiden rankings. Frontier IP's involvement with ScienceIN2Business reflects the Group's growing reputation within Portugal, where it currently has three spin outs from NOVA University Lisbon, NOVA School of Science and Technology, and the Institute for Systems and Computer Engineering, Technology and Science.

 

The Group is also a partner with the UK government's Department for International Trade in Portugal.

 

ScienceIN2Business Coordinator, Jorge Maia Alves, said: "We strongly believe that having Frontier IP onboard our technology transfer programme will clearly represent an extra value to the teams that will be involved in the ongoing Call for Projects."

 

Frontier IP Chief Executive Officer, Neil Crabb, said: "We are very pleased to become a partner with one of Portugal's leading universities, the University of Lisbon, in its prestigious ScienceIN2Business technology transfer programme. It's a further sign of our growing reputation in the country."

 

 

 ENQUIRIES 

 

Frontier IP Group plc 

www.frontierip.co.uk

 

Neil Crabb, Chief Executive 

T: 020 7332 2338 

 

Andrew Johnson, Communications & Investor Relations 

M: 07464 546 025 

 

 

 

Allenby Capital Limited (Nominated Adviser) 

T: 0203 328 5656 

 

Nick Athanas / Nicholas Chambers

 

 

ABOUT FRONTIER IP 

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs. 

 

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development. 

 

About RNS Reach announcements 

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAMZGMFZRZGGZZ
Date   Source Headline
28th Jun 20247:00 amRNSPortfolio – Cambridge Raman Imaging loan facility
19th Jun 20247:00 amRNSHolding(s) in Company
24th May 20247:00 amRNSTopps Group’s arm launches Alusid floor tile range
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.